Clinical Response to World-First Drug Trial at The Christie

Press/Media: Research

Description

A patient participating in a first-in-human Phase I clinical trial of a novel agent in combination with an immune-checkpoint inhibitor had a complete response to therapy. This news story was picked up nationally and internationally on a large scale

Period4 Feb 2017 → 5 Feb 2017

Media coverage

4

Media coverage

Media contributions

1

Media contributions